Regency Capital Management Inc.\De Amgen Inc Transaction History

Regency Capital Management Inc.\De

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $21,876 - $25,036	-110 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $1,061 - $1,243	5 Added 4.76%	110 $23,000
Q2 2021 Jul 07, 2021	SELL	$233.58 - $259.14 $467 - $518	-2 Reduced 1.87%	105 $26,000
Q1 2021 May 25, 2021	BUY	$221.91 - $258.6 $23,744 - $27,670	107 New	107 $27,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Regency Capital Management Inc.\De, based on Form 13F filings with the SEC.

Stay updated on Regency Capital Management Inc.\De with notifications on news.